Beginning a new role as a pharmacoepidemiologist requires a structured approach to quickly understand the organization's research priorities, data sources, and regulatory environment. A 30-60-90 day plan provides a roadmap to establish your expertise, build key relationships, and contribute effectively to pharmacoepidemiologic studies.
This customized 30-60-90 day onboarding plan helps you:
- Define specific research goals aligned with your organization's pharmacoepidemiology projects
- Gain proficiency in relevant databases, analytical tools, and regulatory guidelines
- Establish collaborations with clinical, regulatory, and data science teams
Whether you are joining a pharmaceutical company, academic institution, or regulatory agency, this plan supports your successful transition into the pharmacoepidemiology role.
Benefits of a 30-60-90 Day Plan for Pharmacoepidemiologists
Using this plan offers several advantages tailored to the unique demands of pharmacoepidemiology:
- Provides a structured timeline to master complex epidemiologic methods and data interpretation
- Facilitates early engagement with cross-functional teams critical for study design and implementation
- Helps prioritize learning regulatory frameworks such as FDA and EMA guidelines relevant to drug safety
- Enables setting measurable milestones for contributing to ongoing and new pharmacoepidemiologic research
Main Elements of the Pharmacoepidemiologist 30-60-90 Day Plan
This plan is segmented into three phases, each with clear objectives, tasks, and progress tracking:
First 30 Days: Orientation and Foundation
Focus on understanding your organization's pharmacoepidemiology landscape, including current projects, data infrastructure, and team roles. Key activities include:
- Reviewing existing pharmacoepidemiologic studies and protocols
- Gaining access to and training on relevant databases (e.g., claims data, electronic health records)
- Meeting with key stakeholders such as clinical researchers, biostatisticians, and regulatory affairs
- Familiarizing yourself with applicable regulatory guidelines and safety reporting requirements
Next 30 Days (Days 31-60): Skill Development and Integration
Deepen your technical expertise and begin contributing to study design and data analysis. Activities include:
- Conducting preliminary data analyses under supervision
- Participating in protocol development and review meetings
- Collaborating with cross-functional teams to align research objectives
- Attending relevant training sessions on pharmacoepidemiologic methods and software tools
Final 30 Days (Days 61-90): Contribution and Leadership
Take on greater responsibility by leading specific tasks and contributing to study outputs. Focus areas include:
- Designing and implementing pharmacoepidemiologic analyses independently
- Preparing reports and presentations for internal and external stakeholders
- Identifying opportunities for methodological improvements or new research questions
- Providing mentorship to junior team members or interns as appropriate
Throughout all phases, document your progress, challenges, and feedback to facilitate continuous improvement and alignment with your manager and team.
This 30-60-90 day plan equips pharmacoepidemiologists with a clear, actionable framework to accelerate their onboarding and maximize their impact in advancing drug safety and effectiveness research.
